Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice
Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial.However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management.Thus, there is an urgent need to bridge this gap Vitamins between test usage and clini